May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting
HTML-код
- Опубликовано: 23 май 2024
- At this meeting, the committee will discuss the safety and efficacy of biologics license application (BLA) 761326 for NNC0148-0287 injection (insulin icodec), a long-acting insulin analog product, submitted by Novo Nordisk. The proposed indication is to improve glycemic control in adults with diabetes mellitus.
- Наука